Key Takeaways
- • Veritas Capital secured a binding agreement to acquire Bodycote for £1.85 billion (approximately $2.51 billion) on a debt-inclusive basis, defeating rival bidder CVC Capital Partners in a competitive auction process.
- • The offer structure comprises 932.8 pence in cash per share plus a 7.2 pence interim dividend, totaling 940 pence per share, representing approximately a 22% premium to Bodycote's pre-bid trading levels.
- • Veritas Capital, a U.S.-based private equity firm managing $54 billion in assets under management, views Bodycote as an attractive global provider of thermal processing and metal treatment services with significant operational upside potential.
- • The deal concluded a competitive process in which both CVC and Veritas submitted rival proposals valued at approximately £1.6 billion in early August, with Veritas ultimately securing backing from Bodycote's board by announcing a firm offer that satisfied the Rule 2.4 deadline requirement.
Summary
Veritas Capital has completed the acquisition of UK-listed thermal processing services company Bodycote in a £1.85 billion transaction on a debt-inclusive basis, equivalent to approximately $2.51 billion. The U.S.-based private equity firm secured board backing on September 1, 2026, following a competitive bidding process against rival private equity contender CVC Capital Partners.
The final offer structure values Bodycote shares at 940 pence per share, comprising a cash payment of 932.8 pence supplemented by a 7.2 pence interim dividend that shareholders will retain. This valuation represents a meaningful premium of approximately 22% relative to Bodycote's share price prior to the emergence of takeover interest. The deal was announced as a recommended cash acquisition with full board support.
The transaction culminated a month-long auction process initiated in early August 2026 when both CVC Advisers and Veritas Capital submitted competing conditional cash proposals valued at approximately £1.6 billion each. Veritas Capital Fund IX submitted an initial proposal valuing shares at up to 914 pence plus the interim dividend component, which ultimately evolved into the higher final bid. The competitive tension between the two bidders drove the valuation higher, with Veritas securing the prize by improving its offer structure.
Veritas Capital's acquisition strategy reflects confidence in Bodycote's market position as a global provider of metal treatment and thermal processing services. The firm, which oversees $54 billion in assets under management, anticipates meaningful operational improvements and value creation opportunities within the acquired business. The deal represents a significant M&A success for Veritas and eliminates Bodycote from the public markets.
The final offer structure values Bodycote shares at 940 pence per share, comprising a cash payment of 932.8 pence supplemented by a 7.2 pence interim dividend that shareholders will retain. This valuation represents a meaningful premium of approximately 22% relative to Bodycote's share price prior to the emergence of takeover interest. The deal was announced as a recommended cash acquisition with full board support.
The transaction culminated a month-long auction process initiated in early August 2026 when both CVC Advisers and Veritas Capital submitted competing conditional cash proposals valued at approximately £1.6 billion each. Veritas Capital Fund IX submitted an initial proposal valuing shares at up to 914 pence plus the interim dividend component, which ultimately evolved into the higher final bid. The competitive tension between the two bidders drove the valuation higher, with Veritas securing the prize by improving its offer structure.
Veritas Capital's acquisition strategy reflects confidence in Bodycote's market position as a global provider of metal treatment and thermal processing services. The firm, which oversees $54 billion in assets under management, anticipates meaningful operational improvements and value creation opportunities within the acquired business. The deal represents a significant M&A success for Veritas and eliminates Bodycote from the public markets.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.